Skip to Content


In the US, Deferiprone (deferiprone systemic) is a member of the following drug classes: antidotes, chelating agents and is used to treat Hemosiderosis, Iron Overload, Superficial Siderosis and Thalassemia.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Iron chelator

Chemical Name


Foreign Names

  • Deferipronum (Latin)
  • Deferipron (German)
  • Défériprone (French)
  • Deferiprona (Spanish)

Generic Names

Brand Names

  • Deferipron Evolan
    Evolan, Sweden
  • Deferiprone
    Actavis UK, United Kingdom
  • Deferiprone Lipomed
    Lipomed, Poland
  • Ferriprox
    ApoPharma, Canada; ApoPharma, United States; Apotex, Australia; Apotex, China; Apotex, Czech Republic; Apotex, Estonia; Apotex, Greece; Apotex, Hong Kong; Apotex, Lithuania; Apotex, Norway; Apotex, New Zealand; Apotex, Oman; Apotex, Philippines; Apotex, Poland; Apotex, Singapore; Apotex, Thailand; Apotex, Tunisia; Apotex Europe, Cyprus; Apotex Nederland, Netherlands; Chiesi, Latvia; Chiesi, Turkey; Chiesi Farmaceutica, Brazil; Chiesi Farmaceutici, Italy; Pharma Logistics, Belgium; Quamed/Apotex, Indonesia; SOBI, Sweden; Sobi - Swedish Orphan Biovitrum, Germany; Swedish Orphan, Spain; Swedish Orphan Biovitrum, Denmark; Swedish Orphan Biovitrum, Finland; Swedish Orphan Biovitrum, France; Swedish Orphan Biovitrum, United Kingdom; Swedish Orphan Biovitrum Ltd., Ireland
  • Ferriprox 100mg/ml
    Apotex, Israel; Apotex, Oman; Apotex Europe, Austria; Pharma Logistics, Luxembourg
  • Ferriprox 500mg
    Apotex, Israel; Apotex Europe, Austria; Nordic, Switzerland; Swedish Orphan, Luxembourg
  • Gpo-L-One
    GPO, Thailand
  • Kelfer
    Cipla, Thailand; Cipla, Taiwan


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.